Newsletter | August 30, 2022

08.30.22 -- The Development, Scale-Up, And Manufacturing Of Semi-Solid Dosage Forms

New Podcast Episode
Industry Insights
The Development, Scale-Up, And Manufacturing Of Semi-Solid Dosage Forms

Topical products, whether prescription dermatological drugs or over-the-counter lotions, creams, or gels, present unique challenges in terms of development and manufacturing.

Method Development: Managing A Diverse Range Of APIs

See how the team developed analytical methods to support preclinical and future GMP production under tight timelines.

New Technologies To Improve Solubility Of Brick Dust Compounds

David Lyon, Ph.D., and Molly Adam answer attendee questions from a recent webinar about three enabling technologies designed to improve drug solubility in organic solvents for spray drying.

The Importance Of Immunogenicity

Yvette Stallwood, head of Lonza’s Early Development Services, talks about patient safety and other advantages of early testing for immunogenicity in the drug development journey.

Downstream Digital Twins. Biopharma Going In Silico

Statistical approaches such as Big Data, machine learning, and artificial intelligence utilize statistics to predict trends and patterns. Mechanistic models are, instead, based on physical and biochemical principles.

Promises And Challenges Of AI For Therapeutic Target Identification

Watch this webinar to learn how increasing market and regulatory demands for safety and efficacy are driving pharmaceutical R&D to improve upstream discovery efforts. Discover how AI and machine learning technologies are gaining popularity in extracting knowledge from a multitude of resources and enabling precision medicine.

Reinventing ADME-PK Profiling Strategy For PROTAC Discovery

Gain insights into a practical strategy to delineate drugability issues associated with PROTAC programs and understand more about custom based ADME assays and PK studies that drive the SAR in PROTAC research.

Most Popular News
Life Science Leader Magazine

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.